Cathie Wood Takes Profit On Hot AI Stock Palantir Again, Continues To Sell Block Shares Amid Bitcoin Buzz - ARK Innovation ETF (BATS:ARKK)

On Thursday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc (NASDAQ:PLTR). and Block Inc. (NYSE:SQ). Notably, the firm had sold shares of both these companies ahead of Christmas as well.

The Palantir Trade

Ark Invest decided to sell 103,410 shares of Palantir Technologies Inc. through its ARK Innovation ETF (NYSE:ARKK). The sale, valued at approximately $8.5 million based on Palantir’s closing price of $82.14, aligns with Ark’s recent trend of reducing its position in Palantir.

Palantir’s stock has seen a remarkable surge, climbing over 380% since the beginning of the year, largely due to its strong positioning in the AI sector. This rally gained momentum in November following the company’s impressive quarterly results, which highlighted robust demand for AI solutions.

The Block Trade

Other Key Trades:

GitLab Inc: Ark Invest purchased 219,606 shares through the ARKK.
CRISPR Therapeutics AG: A buy of 57,889 shares was made by Ark through the ARKK.
Adaptive Biotechnologies Corp: Ark sold 75,957 shares from the ARKG.

Read Next:

Mark Cuban’s Surprising Purchase Of A Whole Town Near Dallas Was A Favor For A Friend – And He Wanted To Rename It To Dinosaur, Texas

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

The Palantir Trade

The Block Trade

In another strategic move, Ark Invest sold 15,342 shares of Block Inc. from ARKK. This transaction was valued at approximately $1.4 million, calculated from Block’s closing price of $91.48. Block, previously known as Square, has been a key player in the digital payments space and has a Bitcoin (CRYPTO: BTC) focus. Bitcoin has been in focus as the leading cryptocurrency has been consistently hitting new all-time highs this year. For more insights into Ark’s recent trading activities, visit this Benzinga report.

Other Key Trades:

GitLab Inc: Ark Invest purchased 219,606 shares through the ARKK.
CRISPR Therapeutics AG: A buy of 57,889 shares was made by Ark through the ARKK.
Adaptive Biotechnologies Corp: Ark sold 75,957 shares from the ARKG.

Read Next:

Mark Cuban’s Surprising Purchase Of A Whole Town Near Dallas Was A Favor For A Friend – And He Wanted To Rename It To Dinosaur, Texas

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

$BTCBitcoin

$68022.33-0.15%

Overview

ARKKARK Innovation ETF

$72.33-0.10%

PLTRPalantir Technologies Inc

$156.60-0.36%

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.